Soleno Therapeutics, Inc.
SLNO
$73.64
$0.380.52%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 291.44M | 256.78M | 266.12M | 149.63M | 169.68M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.45M | 1.42M | 1.38M | 1.60M | 1.68M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 293.89M | 258.20M | 267.50M | 151.22M | 171.36M |
|
|
|||||
| Total Current Assets | 293.89M | 258.20M | 267.50M | 151.22M | 171.36M |
| Net Property, Plant & Equipment | 2.98M | 3.19M | 287.00K | 365.00K | 419.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 6.81M | 7.29M | 7.78M | 8.26M | 8.75M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 83.00K | 83.00K | 83.00K | 165.00K | 165.00K |
| Total Assets | 330.97M | 296.71M | 304.13M | 168.84M | 180.69M |
|
|
|||||
| Total Accounts Payable | 8.88M | 6.24M | 3.72M | 8.02M | 3.15M |
| Total Accrued Expenses | 6.60M | 5.17M | 4.01M | 3.62M | 6.53M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 526.00K | 448.00K | 296.00K | 310.00K | 273.00K |
| Total Finance Division Other Current Liabilities | 2.74M | 3.10M | 1.13M | 1.51M | 1.56M |
| Total Other Current Liabilities | 2.74M | 3.10M | 1.13M | 1.51M | 1.56M |
| Total Current Liabilities | 18.75M | 14.96M | 9.15M | 13.46M | 11.51M |
|
|
|||||
| Total Current Liabilities | 18.75M | 14.96M | 9.15M | 13.46M | 11.51M |
| Long-Term Debt | 49.83M | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.47M | 2.58M | -- | 37.00K | 130.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 14.81M | 14.46M | 14.22M | 11.95M | 11.55M |
| Total Liabilities | 85.86M | 32.01M | 23.37M | 25.45M | 23.18M |
|
|
|||||
| Common Stock & APIC | 697.01M | 660.08M | 600.57M | 441.30M | 433.92M |
| Retained Earnings | -452.26M | -396.28M | -319.66M | -297.81M | -276.41M |
| Treasury Stock & Other | 361.00K | 895.00K | -153.00K | -106.00K | -- |
| Total Common Equity | 245.11M | 264.70M | 280.76M | 143.39M | 157.51M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 245.11M | 264.70M | 280.76M | 143.39M | 157.51M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 245.11M | 264.70M | 280.76M | 143.39M | 157.51M |
|
|
|||||